US FDA Warns Docs On Gastric Balloon Adverse Events

Gastric balloons from ReShape Medical and Apollo Endosurgery have been tied to pancreatitis and problems caused by over-inflation, the agency says.

US FDA issued a letter to health-care providers Feb. 9 warning of risks posed by a intragastric balloons used to treat obesity.

The agency says it’s received multiple reports of two kinds of adverse events tied to the use of fluid-filled intragastric...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation